1-2 of 2
Bernd Dörken
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma

Anne Steininger, Markus Möbs, Reinhard Ullmann, Karl Köchert, Stephan Kreher, Björn Lamprecht, Ioannis Anagnostopoulos, Michael Hummel, Julia Richter, Marc Beyer, Martin Janz, Claus-Detlev Klemke, Harald Stein, Bernd Dörken, Wolfram Sterry, Evelin Schrock, Stephan Mathas, Chalid Assaf
Journal: Journal of Experimental Medicine
J Exp Med (2011) 208 (8): 1585–1593.
https://doi.org/10.1084/jem.20101785
Published: 25 July 2011
View article titled, Genomic loss of the putative tumor suppressor gene E2A in human lymphoma
Open the PDF for Genomic loss of the putative tumor suppressor gene E2A in human lymphoma in another window
Includes: Supplementary data
Journal Articles

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma

Bernhard Gillissen, Jana Wendt, Antje Richter, Anja Richter, Annika Müer, Tim Overkamp, Nina Gebhardt, Robert Preissner, Claus Belka, Bernd Dörken, Peter T. Daniel
Journal: Journal of Cell Biology
J Cell Biol (2010) 188 (6): 851–862.
https://doi.org/10.1083/jcb.200912070
Published: 22 March 2010
View article titled, Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma
Open the PDF for Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma in another window
Includes: Supplementary data